missing translation for 'onlineSavingsMsg'
Learn More

Fevipiprant, MedChemExpress

Product Code. 16483207
Encompass_Preferred
Change view
Click to view available options
Quantity:
5 mg
10 mg
25 mg
50 mg
100 mg
200 mg
Unit Size:
100mg
10mg
200mg
25mg
50mg
5mg
6 product options available for selection
Product selection table with 6 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16483207 50 mg 50mg
16467176 100 mg 100mg
16459717 5 mg 5mg
16457188 10 mg 10mg
16433546 25 mg 25mg
16431236 200 mg 200mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 6 options available.
6 options
This item is not returnable. View return policy
Product Code. 16483207 Supplier Medchem Express Supplier No. HY16768

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Fevipiprant (QAW039; NVP-QAW039) is a selective, potent, reversible competitive CRTh2 antagonist with an in vitro dissociation constant KD value of 1.1nM at the CRTh2 receptor and an IC50 value of 0.44 nM for inhibition of PGD2-induced eosinophil shape change in human whole blood.

Fevipiprant (QAW039

Specifications

Chemical Name or Material Fevipiprant
CAS 872365-14-5
Color White
Purity Grade Notes Research
Molecular Formula C19H17F3N2O4S
Quantity 50 mg
Synonym QAW039 NVP-QAW039
Solubility Information DMSO : ≥ 32 mg/mL (75.05 mM)
SMILES O=C(O)CC1=C(C)N(CC2=CC=C(S(=O)(C)=O)C=C2C(F)(F)F)C3=NC=CC=C31
Molecular Weight (g/mol) 426.41
Formula Weight 426.41
Percent Purity 98.06%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.